Analysis of medicine advertisement produced in Brazil
Main Article Content
Keywords
Advertising, Periodicals, Drug Industry, Brazil
Abstract
Objective: To analyze the compliance of drug advertisements with regulations in Brazil, subject to Resolution RDC No. 102/2000 since 2000, which abides by the WHO’s (World Health Organization) Ethical Criteria for Medicinal Drug Promotion, published in 1988.
Methods: Drug advertisements running within the period of October 2002 to October 2003 were collected and recorded. Media sources included various AM and FM radio stations, television channels, newspapers, and magazines, as well as printed material distributed in doctors’ offices, hospitals, drugstores, conferences, billboards, and bus doors. All sources were located in Curitiba City, Brazil, and its surrounding area. Advertisement content was analyzed according to a conformity checklist prepared based on the legal requirements of RDC No. 102/00.
Results: A total of 827 advertisements for 517 different products, 83.91% regularly registered as medicinal drugs and 16.09% unregistered products that should be registered according to the Brazilian regulations, were recorded and collected. Approximately 74.73% of the advertisements did not comply with regulations; on average, such advertisements had 4.6 infractions each.
Conclusions: The results of this research suggest that RDC No. 102/00 is not followed, which strengthens the need to adopt new forms of regulation to prohibit excesses of the pharmaceutical industry and to protect the population from abusive and misleading drug advertising.
References
2. de Santi V. Medicamentos: verso e reverso da propaganda. Ponta Grossa: UEPG; 1999.
3. Heineck I, Gallina SM, Silva T, Pizzo FD, Schenkel EP. Analise da publicidade de medicamentos veiculada em emissoras de radio do Rio Grande do Sul, Brasil. Cad Saude Publica. 1998;14(1):193-8.
4. Pizzol FD, Silva T, Schenkel EP. Analise da adequacao das propagandas de medicamentos dirigidas a categoria medica distribuidas no sul do Brasil. Cad Saude Publica. 1998;14(1):85-91.
5. Silva EV, Hoefler R, Moraes LB. Avaliação das propagandas de medicamentos distribuídas para a classe médica de Brasília. Farmacoterapêutica. 1999;IV(4):1-3.
6. Organización Mundial de la Salud. Critérios éticos para la promoción de medicamentos. Geneve: OMS; 1988.
7. Agencia Nacional de Vigilância Sanitária (ANVISA). RDC nº 102/00. Aprova o Regulamento sobre propagandas, mensagens publicitarias e promocionais e outras práticas(...). 2000 Dez 01 [cited 2004 Mar 01]; Available from: www.anvisa.gov.br
8. Carvalho ACB, Fernandes MG, Santos EJV, Melo AFM, Medeiros IA, Diniz MFFM. Avaliação legal da propaganda e publicidade de medicamentos fitoterápicos anunciados na Paraíba (Brasil). Acta Farmaceutica Bonarense. 2004;23(3):413-7.
9. Mastroianni PC, Galduroz JC, Carlini EA. Influence of the legislation on the advertisement of psychoactive medications in Brazil. Rev Bras Psiquiatr 2003;25(3):146-55.
10. Nascimento AC. A persistirem os sintomas o médico deverá ser consultado: isto é regulação? São Paulo: Sobravime; 2005.
11. Resener MC. Análise da qualidade de propagandas de medicamentos fitoterápicos disponibilizadas em Santa Catarina [MSc Thesis]. Florianópolis: Universidade Federal do Paraná; 2004.
12. Petrovick PR, Lima MA. Avaliação da Publicidade Visual de Medicamentos em Estabelecimentos Farmacêuticos de Porto Alegre-RS. Infarma (Revista Pharmacia Brasileira). 2003;15(1/3):52-6.
13. Costa EA. Vigilância Sanitária a Defesa e Proteção da Saúde [PhD Thesis]. São Paulo: Universidade de São Paulo; 2004.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.